Welcome Guest Updated      Mumbai : Sep 05 03:19     New York : Sep 04 16:49      London : Sep 04 21:49     Tokyo : Sep 05 06:49 |     HOME
 
 
Search Website NAVs
  Business Partner | Employee | Investor
 
 
 
 
 
 
 
Equity Funds
Debt Funds
Liquid Funds
DSP BR Micro-Cap (G)
  03/09/2010   17.0190
DSP BR Micro-Cap (G)
  03/09/2010   17.0190
PSU Bank BeES (G)
  03/09/2010   439.6897
PSU Bank BeES (G)
  03/09/2010   439.6897
Reliance Banking (B)
  03/09/2010   102.4153
Reliance Banking (B)
  03/09/2010   102.4153
Reliance Banking IP (D)
  03/09/2010   99.2903
Reliance Banking IP (D)
  03/09/2010   99.2903
Reliance Pharma (B)
  03/09/2010   52.3977
Reliance Pharma (B)
  03/09/2010   52.3977
Reliance Pharma (D)
  03/09/2010   39.0825
Reliance Pharma (D)
  03/09/2010   39.0825
Reliance Pharma (G)
  03/09/2010   52.4010
Reliance Pharma (G)
  03/09/2010   52.4010
Religare Mid N Small (D)
  03/09/2010   15.2400
Religare Mid N Small (D)
  03/09/2010   15.2400
Religare Mid N Small (G)
  03/09/2010   15.2500
Religare Mid N Small (G)
  03/09/2010   15.2500
SBI MagSFU FMCG (G)
  03/09/2010   29.8400
SBI MagSFU FMCG (G)
  03/09/2010   29.8400
 
About Us Products Research Desk Learning Center News Career Download Contact Us
 
Products Mutual Funds Scheme Profile
 
Scheme Details NAVs Portfolio NAV Charts Fund Profile
Franklin Pharma Fund
AMC Franklin Templeton Asset Management (India) Pvt. Ltd.
Fund Franklin Templeton Mutual Fund Category Equity - Sector Fund
Scheme Plan Growth Scheme Type Open Ended
Inception Date 31/3/1999 Fund Manager Mr.  Anand Radhakrishnan
Initial Price Rs. 10 Min. Investment Rs. 5000
Objectives Seeks to provide long term capital appreciation by investing primarily in shares of companies operating in Pharmaceutical/ Life Sciences industry. 
Entry Load nil
Exit Load 1
  Value As on
Latest NAV Rs. 58.42 03/09/2010
Net Asset Size Rs. 125.27 Crores 30/07/2010
Last Dividend 25.00% 24/10/2007
Assets Break-up (as on 30-07-2010) %age
Equity 86.79
Current Assets 13.21
Absolute Return (as on 03/09/2010)
1 Week 1 Month 3 Months 6 Months 9 Months 1 Year
1.62% 1.32% 3.24% 16.45% 23.26% 61.83%
Mutual Fund Registrar
Bandra Kurla Complex, 4th Floor, Wockhardt Towers, Bandra (East), Mumbai, Maharashtra, India, 400051
Email: service@templeton.com
Web: http://www.franklintempletonindia.com
Franklin Templeton Asset Management (India) Pvt. Ltd., Karvy Computershare Pvt. Ltd.
News Details
Date Headline
04/08/2010 Franklin Templeton Fixed Tenure Fund-Series XV files offer document with Sebi
05/07/2010 Franklin Templeton MF Announces Change in key personnel
01/07/2010 Franklin Templeton MF Declares Dividend for Templeton India Income Opportunities Fund
30/06/2010 Franklin Templeton MF to Introduce SWP Facility in Templeton India Short Term Income Plan
30/06/2010 Franklin Templeton MF to Revise Exit Load Structure Under 2 Schemes
 
PRODUCTS
Mutual Funds
  About Mutual Funds
  MF News
  NAV's
  Dividends
  Search
  Forthcoming Funds
  Open Issues
  Close Issues
  Gainers
  Losers
  Top Performers
  Best Performing Fund
  Mutual Fund Activities
  Mobilization
  Fund Compare
  Scheme Compare
  SIP Calculator
  Tax Implications
Insurance
IPO's
Bond & FD's
Financial Planning
PRODUCT OFFERINGS
 
Banks accept deposit money from investor’s with a promise to give them certain profit on their deposits. This money then invested into different instruments, where they get higher returns than what they have promised depositors…
Read More
 
In today's world Life Insurance has become basic investment need to secure from uncertain future…
Read More
 
Even in the new age Financial World Bond & FDs look attractive with regular intervals and it continues to be a part of every portfolio. We suggest investors when & which FD would give them better post tax yield…
Read More
 
Equity IPO’s have given huge returns to investors in the past. Every IPO Company has to be profitable for past 3 years and the same company’s valuations are analyzed and then it gets its deserving price band.
Read More
 
Sitemap      Contact Us      Disclaimer  
© Copyright 2008 RELIGARE All rights reserved.